Bayer HealthCare has agreed to pay $3.2 million to settle a Federal Trade Commission suit charging it ran misleading advertisements about its One-A-Day WeightSmart vitamins.

The suit and a consent order, filed last week in U.S. District Court in Newark, N.J., are the result of an FTC crackdown on diet pill makers that has produced three other settlements, totaling $25 million, since October.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]